A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).
Study unveils key immune cells found to boost cancer treatment success in acute myeloid leukemia
